amylyx.comHealthcareFounded: 2014Funding to Date: $203.25MM
Amylyx is a pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases.
For more details on financing and valuation for Amylyx, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Amylyx.
To read this article and more news on Amylyx, register or login.
